Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)

Clinical trials sponsored by Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi), explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1

Can a cholesterol drug prevent heart attacks in rare genetic disorder?

Disease control Ongoing

This study aims to see if the drug lomitapide reduces major heart-related events like heart attacks and strokes in people with a rare, severe form of genetic high cholesterol (HoFH). It will compare the number of these events in 73 patients during their first three years on the d…

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC